Webinar – Clinical consequences of the New MASLD Nomenclature
On the 27th of June, we organized the webinar: ‘Clinical Consequences of the New MASLD Nomenclature‘ with guest speaker Prof. Maja Thiele.
During this webinar, our speaker and hosts dived into the following topics:
- Is the MASLD nomeclature of prognostic relevance?
- Do we need to re-validate all NILTs after the new nomenclature?
- Considerations for “the new kid in town”: MetALD
Speakers, hosts, and audience
- Speaker: Prof. Maja Thiele
- Hosts: Prof. Manuel Castro Cabezas & Prof. Christophe Moreno
- Audience: Clinicians, researchers, pharmaceutical industry workers, public health workers
You can watch the replay here: https://vimeo.com/973037860
Â
Related webinars
Webinar – Revolutionizing Kidney Failure Treatment: Clinical Impact and Lessons Learned from the CONVINCE Clinical Trial
On December 12th, we organised the webinar:Revolutionizing Kidney Failure Treatment: Clinical Impact and Lessons Learned from the CONVINCE Clinical TrialDuring this webinar, our speaker and hosts explored the following topics:Study d...
Webinar: Lifestyle Interventions in NAFLD/NASH
On the 19th of September, we presented the 9th webinar of our NASH Webinar Series. During this webinar, speaker Professor Zelber-Sagi explored the relationship between diet and NAFLD, emphasizing that diet not only causes NAFLD but can also serve ...
Webinar: Why NASH trials frequently fail and how to improve them
On May 23, we presented the webinar: Why NASH trials frequently fail and how to improve themGuest speaker: Professor Manuel Castro Cabezas Host: Professor Diederick E. GrobbeeFill in the form and watch the replay: ...